These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6346595

  • 1. Medical research council trial of antilymphocyte globulin in renal transplantation. A multicenter randomized double-blind placebo controlled clinical investigation.
    Bell PR, Blamey RW, Briggs JD, Castro JE, Hamilton DN, Knapp MS, Salaman JR, Sells RA, Williams G, Gowans JL, Peto R, Richards S, Phillips AW, Weinberg AL, Freestone DS.
    Transplantation; 1983 Jun; 35(6):539-45. PubMed ID: 6346595
    [Abstract] [Full Text] [Related]

  • 2. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G, Walsh G, Deshpande P, Koffman G.
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [Abstract] [Full Text] [Related]

  • 3. Acute rejection episodes after renal transplantation in children.
    Hoyer PF, Offner G, Brodehl J.
    Clin Nephrol; 1983 Feb; 19(2):61-6. PubMed ID: 6340876
    [Abstract] [Full Text] [Related]

  • 4. Immunosuppressive treatment of primary cadaveric renal transplant patients receiving kidneys from non-heart beating donors.
    Ohshima S, Fujita T, Ono Y, Kinukawa T, Katoh N, Matsuura O.
    Artif Organs; 1996 Oct; 20(10):1130-6. PubMed ID: 8896734
    [Abstract] [Full Text] [Related]

  • 5. Antilymphocyte globulin in cadaveric renal transplantation--a controlled trial.
    Jakobsen A, Sødal G, Flatmark A, Thorsby E.
    Scand J Urol Nephrol Suppl; 1977 Oct; (42):94-6. PubMed ID: 356233
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial.
    Hanto DW, Jendrisak MD, So SK, McCullough CS, Rush TM, Michalski SM, Phelan D, Mohanakumar T.
    Transplantation; 1994 Feb; 57(3):377-84. PubMed ID: 8108873
    [Abstract] [Full Text] [Related]

  • 8. [Use and limits of preventive antilymphocyte globulin therapy following kidney transplantation. A prospective randomized study].
    Grundmann R, Wienand P, Meider G, Vlaho V, Pichlmaier H.
    Klin Wochenschr; 1984 Oct 15; 62(20):979-85. PubMed ID: 6389973
    [Abstract] [Full Text] [Related]

  • 9. Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy.
    Stratta RJ, D'Alessandro AM, Armbrust MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplantation; 1989 Jan 15; 47(1):96-102. PubMed ID: 2643236
    [Abstract] [Full Text] [Related]

  • 10. Treatment of renal transplant rejection episodes in patients receiving prednisone and azathioprine. A cost-effective approach.
    Matas AJ, Tellis VA, Quinn T, Karwa G, Glichlick D, Soberman R, Veith F.
    Transplantation; 1985 Jul 15; 40(1):35-9. PubMed ID: 3892794
    [Abstract] [Full Text] [Related]

  • 11. Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study.
    Novick AC, Hwei HH, Steinmuller D, Streem SB, Cunningham RJ, Steinhilber D, Goormastic M, Buszta C.
    Transplantation; 1986 Aug 15; 42(2):154-8. PubMed ID: 3526655
    [Abstract] [Full Text] [Related]

  • 12. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
    Canafax DM, Torres A, Fryd DS, Heil JE, Strand MH, Ascher NL, Payne WD, Sutherland DE, Simmons RL, Najarian JS.
    Transplantation; 1986 Feb 15; 41(2):177-81. PubMed ID: 3511581
    [Abstract] [Full Text] [Related]

  • 13. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants.
    Sansom JR, Barnes AD, Hall CL.
    Postgrad Med J; 1976 Feb 15; 52(5 Suppl):75-8. PubMed ID: 792851
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW.
    Transplantation; 1995 Aug 15; 60(3):225-32. PubMed ID: 7645033
    [Abstract] [Full Text] [Related]

  • 17. The use of antilymphoblast globulin in the treatment of renal allograft rejection: a double-blind, randomized study.
    Howard RJ, Condie RM, Sutherland DE, Simmons RL, Najarian JS.
    Transplantation; 1977 Dec 15; 24(6):419-23. PubMed ID: 339438
    [Abstract] [Full Text] [Related]

  • 18. Low-dose maintenance prednisone and antilymphoblast globulin for the treatment of acute rejection. A steroid-sparing approach to immunosuppressive therapy.
    Streem SB, Novick AC, Braun WE, Steinmuller D, Greenstreet R.
    Transplantation; 1983 May 15; 35(5):420-4. PubMed ID: 6342219
    [Abstract] [Full Text] [Related]

  • 19. The use of antilymphocyte globulin in renal allograft rejection. A controlled study.
    Birkeland SA.
    Postgrad Med J; 1976 May 15; 52(5 Suppl):82-8. PubMed ID: 792853
    [Abstract] [Full Text] [Related]

  • 20. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
    Slakey DP, Johnson CP, Callaluce RD, Browne BJ, Zhu YR, Roza AM, Adams MB.
    Transplantation; 1993 Oct 15; 56(4):827-31. PubMed ID: 8212201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.